跳至主要内容
临床试验/NCT00480753
NCT00480753已完成2 期

Phase II Dose Response Study of a Topical Gel Formulation of Nitroglycerin, MQX-503, in the Treatment of Raynaud's Phenomenon

MediQuest Therapeutics2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2007年5月1日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
15
试验地点
2
主要终点
Changes in blood flow in the fingers of the non-dominant hand after the induction of constriction of blood vessels by exposure to local cold temperatures.

研究概览

简要总结

The purpose of this clinical study is to determine the response to two different dosage strengths of a topical nitroglycerin gel in patients with Raynaud's Phenomenon. Patient fingers will be monitored for changes in blood flow and skin temperature. Symptoms of pain, tingling and numbness will also be monitored.

详细描述

It is the intention of this protocol to study, in a controlled manner, the response of fingers of patients with Raynaud's phenomenon to two dosage strengths of a fast acting topical formulation of Nitroglycerin, MQX-503. Patients may have moderate to severe primary Raynaud's phenomenon or Raynaud's phenomenon secondary to autoimmune diseases such as scleroderma.

Quantitative changes in blood flow in the fingers of the non-dominant hand will be measured after the clinical induction of constriction of blood vessels by exposure to local cold temperatures. Secondarily, the quantitative reduction in skin temperature recovery time and symptoms of pain, tingling and numbness associated with Raynaud's phenomenon will be evaluated using a patient hand symptom analog assessment score. The frequency and severity of adverse events associated with MQX-503 will be assessed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with Raynaud's phenomenon
  • Patients who are willing to discontinue any current therapies for Raynaud's phenomenon

排除标准

  • The use of any medication containing nitroglycerin or known to interact with nitroglycerin
  • Patients with a history of migraine or other severe headaches
  • Open skin lesions or skin conditions in the area where medication is to be applied
  • Pregnant or nursing women or those wishing to become pregnant.

结局指标

主要结局

Changes in blood flow in the fingers of the non-dominant hand after the induction of constriction of blood vessels by exposure to local cold temperatures.

时间窗: 130 minutes

次要结局

  • Reduction in skin temperature recovery time and symptoms in the fingers of the non-dominant hand after the induction of constriction of blood vessels by exposure to local cold temperatures.(130 minutes)
  • Frequency and severity of adverse events(2 weeks)

研究者

发起方
MediQuest Therapeutics
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验